Skip to main content

Day: April 3, 2023

Juggernaut Announces Strategic Investment by Crescat Capital for 19.17% Ownership; Dr. Quinton Hennigh Technical Advisor

VANCOUVER, British Columbia, April 03, 2023 (GLOBE NEWSWIRE) — Juggernaut Exploration Ltd. (TSX-V: JUGR) (OTCQB: JUGRF) (FSE: 4JE) (the “Company” or “Juggernaut”) is pleased to announce a non-brokered flow through financing of up to $3.0 million dollars. Crescat Capital LLC (“Crescat”) has agreed to make a strategic investment representing a 19.17% ownership of the Company post funding on a partially diluted basis. Juggernaut welcomes this strategic investment from Crescat Capital and technical support from Dr Quinton Hennigh. Juggernaut’s projects continue to garner strong interest and support from leading institutions and miners alike, confirming the quality of its three fully permitted, 100% controlled, drill ready projects located in world class geologic terrane of Northwestern British Columbia and the Golden Triangle. Dr....

Continue reading

Trailbreaker Resources Receives Structural Report, Drill Recommendations for Atsutla Gold Project, Northwestern BC

Figure 1: Detailed geological map of the Swan mineralized zone.VANCOUVER, British Columbia, April 03, 2023 (GLOBE NEWSWIRE) — Trailbreaker Resources Ltd. (TBK.V) (“Trailbreaker” or “the Company”) is pleased to announce that it has received a geological study from Terrane Geoscience Inc. (“Terrane”) with recommended drill holes for Trailbreaker’s 100%-owned Atsutla Gold project, located in northwestern British Columbia (BC). While discussing potential deposit models for the project, the report summarized that there is good evidence of a porphyry-epithermal system, as well as possible orogenic-type mineralization. It was also determined that many features of the Swan zone suggest it represents the shallow, lithocap levels of a porphyry copper system. Daithi Mac Gearailt, CEO of Trailbreaker, commented, “We are very excited to...

Continue reading

Passive Optical Network Market Size Expected to Reach USD 35.59 Billion, at a 14.5% CAGR, by 2030

According to Fortune Business Insights, the global Passive Optical Network Market size is projected to reach USD 35.59 Billion by 2030, at a CAGR of 14.5% during the forecast period, 2023-2030 Pune, India, April 03, 2023 (GLOBE NEWSWIRE) — The global passive optical network market size was valued at USD 12.27 billion in 2022. The market is projected to grow from USD 13.76 billion in 2023 to USD 35.59 billion by 2030, exhibiting a CAGR of 14.5% during the forecast period. Growing Demand for Low Ownership Cost, Reliable Network, and High ROI to Drive Market. Fortune Business Insights provide this information in its report titled “Global Passive Optical Network Market Forecast, 2022-2030.” Key Industry Development: December 2022: Nokia’s bell labs and research wing, with its latest prototype, has expanded into broadband network technology...

Continue reading

Iris Energy provides 5.5 EH/s installation update

Iris Energy provides 5.5 EH/s installation update 2.8 EH/s operating, 2.0 EH/s delivered, 0.7 EH/s in transit Additional share acquisition by director SYDNEY, Australia, April 03, 2023 (GLOBE NEWSWIRE) — Iris Energy Limited (NASDAQ: IREN) (together with its subsidiaries, “Iris Energy”, “the Company” or “the Group”), a leading owner and operator of institutional-grade, highly efficient Bitcoin mining data centers powered by 100% renewable energy, today provided an update on the installation of its 5.5 EH/s of operating capacity. 5.5 EH/s installation update Iris Energy is pleased to advise that it has increased its operating hashrate from 2.0 EH/s to a current level of 2.8 EH/s (as part of the Company’s recently announced increase in self-mining capacity to 5.5 EH/s). An additional 2.0 EH/s of miners have been delivered and are...

Continue reading

Windtree Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Key Business Updates

WARRINGTON, Pa., April 03, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for cardiovascular disorders, today reported financial results for the fourth quarter and fiscal year ended December 31, 2022 and provided key business updates. “We continued to advance our cardiovascular platform during the fourth quarter of 2022 and early 2023 with study start up preparations for the istaroxime SEISMiC extension study in early cardiogenic shock, new patent issuances for istaroxime, new publications, and data presentations at scientific conferences,” said Craig Fraser, President and Chief Executive Officer of Windtree. “We believe all these activities reflect the quality of the science, data, and opportunity with istaroxime and our next...

Continue reading

Salona Global Closes the Biodex Acquisition, Adding $26 Million in Projected Annual Revenue; Posts Audited Year-End Financial Statements with 167% Revenue Growth

SAN DIEGO, April 03, 2023 (GLOBE NEWSWIRE) — Salona Global Medical Device Corporation (“Salona Global”, “SGMD” or the ‎‎“Company”) (TSXV:SGMD) today announced it has closed the acquisition of all of the capital stock of Biodex Medical Systems, Inc., which consists principally of the Biodex Physical Medicine (Rehabilitation) business (“Biodex”), expected to add $26 million in annual revenue to the Company, with an estimated 30% gross margin. The Company also posted its audited year-end financial statements for the ten month transition period ended December 31, 2022, with a total of $33.6 million in revenue with 31.4% gross margins for the period. As previously announced, the Company changed its fiscal year from a February 28 year-end to a December 31 year-end, thereby creating this initial ten month transition period. With the addition...

Continue reading

AIM ImmunoTech Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

– Company continues to execute across development pipeline of high-value indications with 12 active clinical programs – Well-positioned to achieve multiple near-term, value-driving milestones – Company to host inaugural conference call and webcast today at 8:30 AM ET OCALA, Fla., April 03, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, today reported its financial results for the fourth quarter and full year 2022 and provided a business update. As previously announced, the Company will host its inaugural conference call and audio webcast, today, Monday, April 3, 2023, at 8:30 AM ET (details below). “2022 was a year marked by continued...

Continue reading

Teck Board of Directors Rejects Unsolicited Acquisition Proposal

Board determines unsolicited proposal is not in the best interest of TeckTeck’s Board affirms it is not contemplating a sale of the company at this time Planned Separation unlocks a broader range of strategic opportunities Unsolicited proposal carries high degree of execution and timing risk Teck’s Board continues to recommend shareholders vote in favour of proposed Separation and Dual Class AmendmentVANCOUVER, British Columbia, April 03, 2023 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) today announced that the Board of Directors of Teck has received and unanimously rejected an unsolicited and opportunistic acquisition proposal from Glencore plc, which would see that company acquire Teck and subsequently separate to create two businesses, which would expose Teck shareholders to thermal...

Continue reading

Liquidia and GSK Restructure License to PRINT Technology for Inhaled Applications

New agreement supersedes the collaboration agreement entered in 2012 GSK retains non-exclusive right to use PRINT for pre-clinical research for inhaled delivery Liquidia can apply PRINT to any inhaled application other than identified GSK proprietary moleculesMORRISVILLE, N.C., April 03, 2023 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) announced today that it has entered a new, non-exclusive license agreement with GSK to enable pre-clinical research of inhaled formulations of GSK’s molecules based upon Liquidia’s proprietary PRINT® technology. This agreement supersedes the collaboration agreement between the parties from 2012. Liquidia now will have the right to apply PRINT to all inhaled formulations other than certain identified GSK proprietary molecules. GSK will retain a non-exclusive,...

Continue reading

Brown & Brown, Inc. announces the acquisition of Highcourt Breckles Group

DAYTONA BEACH, Fla., April 03, 2023 (GLOBE NEWSWIRE) — J. Scott Penny, chief acquisitions officer of Brown & Brown, Inc. (NYSE:BRO), and Mark R. McKay and Chris Coniglio announce that Brown & Brown has completed the acquisition of Highcourt Partners Limited and its subsidiaries eUnderwriters and CLIS. Highcourt Partners Limited was founded in 2011 as an entrepreneurial international insurance brokerage and risk consulting firm. On April 7th, 2021, Highcourt Partners Limited transformed into the Highcourt Breckles Group (HBG) when it merged with the Breckles Group, a Toronto-based agency with a 70 year history of providing insurance solutions for its customers. HBG’s purpose is to help Canadian businesses be more competitive and assist individuals in preserving their wealth wherever they may be. They have consistently...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.